Correlation of preferentially expressed antigen of melanoma (PRAME) gene expression with clinical characteristics in acute leukemia patients.
Nagaraj V KulkarniReshma A ShettySuchetha Kumari NVijith V ShettyRajesh KrishnaMeenakshi ArumugamAkanksha A KalalPrashanth ShettyPublished in: Journal, genetic engineering & biotechnology (2022)
PRAME gene expression in AL patients was highly expressed, comparable to studies reported globally with significant cytogenetic results. PRAME gene could be used as a potential diagnostic marker for monitoring the malignancies and minimal residual disease in AL.